Glipizide
- Product NDC
- 50090-7404
- 11-digit product format
- 500907404
- Labeler code
- 50090
- Product ID
- 50090-7404_adc62d58-6dab-4189-ba0d-a287cec2c283
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Glipizide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA074497
- Marketing category
- ANDA
- Marketing start
- 2021-12-13
- Substance
- GLIPIZIDE
- Active strength
- 10 mg/1
- Pharmacologic classes
- Sulfonylurea Compounds [CS], Sulfonylurea [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Glipizide
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| GLIPIZIDE | 10 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | X7WDT95N5C |
| Rxcui | 310488 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 50090-7404 | GLIPIZIDE TABLET [A-S MEDICATION SOLUTIONS] | 1 | Current NDC, 5 package rows | 20241027_8948b81f-401c-478e-bb3d-3b0368f5ed8b.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 50090-7404-0 | 50090740400 | 30 TABLET in 1 BOTTLE (50090-7404-0) | 30 tablet | 2024-10-24 | No | No | Current |
| 50090-7404-1 | 50090740401 | 60 TABLET in 1 BOTTLE (50090-7404-1) | 60 tablet | 2024-10-24 | No | No | Current |
| 50090-7404-2 | 50090740402 | 100 TABLET in 1 BOTTLE (50090-7404-2) | 100 tablet | 2024-10-24 | No | No | Current |
| 50090-7404-5 | 50090740405 | 90 TABLET in 1 BOTTLE (50090-7404-5) | 90 tablet | 2024-10-24 | No | No | Current |
| 50090-7404-6 | 50090740406 | 180 TABLET in 1 BOTTLE (50090-7404-6) | 180 tablet | 2024-10-24 | No | No | Current |